Clinical trial
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
Invitation only · Not applicable · 1 countries · Registry ID NCT07239167
Invitation onlyNot applicableObservational
What this study is about
This prospective cohort study collected baseline data and followed up obese patients at their first visit to a weight loss clinic. The study examined the impact of various predictors and biomarkers on weight loss outcomes, aiming to establish an evidence-based foundation for personalized weight loss treatment. Participants underwent a battery of measurements and questionnaires, including height, weight, waist circumference, blood pressure, blood tests, and questionnaires addressing diet, exercise, stress, sleep, measure handgrip strength ,and psychological well-being.
A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.
Basic eligibility
Age18 Years to Not listed
SexAll
Healthy volunteersNot listed
ConditionObesity & Overweight, Weight Loss, Metabolic Syndrome, Metabolic Dysfunction-Associated Steatohepatitis, Obesity (Disorder)
Full registry criteria
Inclusion Criteria: 1. Adults aged 18 years or older, regardless of gender. 2. Body mass index (BMI) ≥ 27 kg/m², or ≥ 24 kg/m² with one or more obesity-related comorbidities. 3. Willing to undergo any form of weight loss intervention. 4. Able to read and understand Chinese, willing to complete questionnaires, blood tests, and follow-up follow-up. 5. Voluntarily consent to participate and be willing to complete the subject consent form. Exclusion Criteria: 1. Pregnant or breastfeeding women. 2. Individuals with significant mental illness (e.g., schizophrenia, severe depression) or cognitive impairment that may affect their ability to consent or cooperate with the study. 3. Individuals with severe organ dysfunction (e.g., end-stage renal disease, cirrhosis, congestive heart failure, etc.). 4. Individuals taking medications that significantly affect their weight (e.g., long-term steroids or antipsychotics) and cannot be discontinued. 5. Individuals deemed unsuitable for participation in this study by the study leader (e.g., individuals who are expected to be unable to complete follow-up).
Treatments and study arms
The registry does not list a named intervention.
Primary outcomes
Baseline data were collected and followed up during the subjects' initial visit to the weight loss clinic to establish an evidence-based basis for personalized weight reduction treatment.Weight changes of subjects after 24 weeks, 48 weeks, 72 weeks, and 96 weeks.
Study locations
1 locations were listed when this page was built. The first 40 are shown.
No.7, Chung Shan S. Rd.（Zhongshan S. Rd.）🇹🇼 Taipei, Zhongzheng Dist, Taiwan